These non-alcoholic beverages include ingredients like nootropics and adaptogens which may boost your mood — without the ...

Sage Therapeutics' financials indicate a need for additional funding in 2025, risking dilution and further financial ...

The global burden of anxiety- and depression-related disorders is on the rise. While multiple drugs have been developed to treat these conditions, current medications have several limitations, ...

Depression continues to grapple a large proportion of the population. Given the side effects associated with the long-term use of conventional antidepressants, there is a need for novel rapid acting ...

Alcohol suppresses excitatory signals while enhancing gamma-aminobutyric acid (GABA), the main inhibitory neurotransmitter in ...

Healthy eating is no longer just a few more salads and a few less sweets. Now you can decrease inflammation by drinking olive ...

Experts say there’s been a rise in young people taking 'Xanax' recreationally in Australia. The drug is usually prescribed to ...

DHM is a flavonoid that is being marketed as a hangover remedy. However, DHM's effectiveness remains unproven. Early studies suggest DHM may protect against alcohol-related liver damage, but these ...

Many alcohol companies have delved into the realm of alcohol-free versions; even Guinness has released a 0% brew.

Sage Therapeutics, Inc. today announced that Chief Executive Officer Barry Greene will discuss the Company's strategic focus areas for 2025 at the 43rd Annual J.P. Morgan Healthcare Conference in San ...

The effects of benzodiazepines on the brain have to do with their ability to bind to the receptors of the neurotransmitter ...

Vistagen Initiates Fasedienol Repeat Dose Study for the Acute Treatment of Social Anxiety Disorder ...